Shorter Pluvicto treatment course for patients with prostate cancer and high initial PSA
Higher pre-treatment PSA levels are associated with fewer real-world Pluvicto cycles
Patient counts by number of Pluvicto treatment cycles undergone. Barplot percentages show the fraction of patients with different PSA levels in blood, measured within 90 days prior to the start of Pluvicto administration. Extracted from both curated and claims data.
Lens Library
